BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li T, Yan B, Ma Y, Weng J, Yang S, Zhao N, Wang X, Sun X. Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination. Cell Death Dis 2018;9:148. [PMID: 29396555 DOI: 10.1038/s41419-017-0182-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Hu B, Zhang D, Zhao K, Wang Y, Pei L, Fu Q, Ma X. Spotlight on USP4: Structure, Function, and Regulation. Front Cell Dev Biol 2021;9:595159. [PMID: 33681193 DOI: 10.3389/fcell.2021.595159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
2 Sarri N, Wang K, Tsioumpekou M, Castillejo-lópez C, Lennartsson J, Heldin C, Papadopoulos N. Deubiquitinating enzymes USP4 and USP17 finetune the trafficking of PDGFRβ and affect PDGF-BB-induced STAT3 signalling. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04128-1] [Reference Citation Analysis]
3 Baek D, Park KH, Lee KM, Jung S, Joung S, Kim J, Lee JW. Ubiquitin-specific protease 53 promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Death Dis 2021;12:238. [PMID: 33664230 DOI: 10.1038/s41419-021-03517-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zhao Y, Xue C, Xie Z, Ouyang X, Li L. Comprehensive analysis of ubiquitin-specific protease 1 reveals its importance in hepatocellular carcinoma. Cell Prolif 2020;53:e12908. [PMID: 32951278 DOI: 10.1111/cpr.12908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tanguturi P, Kim KS, Ramakrishna S. The role of deubiquitinating enzymes in cancer drug resistance. Cancer Chemother Pharmacol 2020;85:627-39. [PMID: 32146496 DOI: 10.1007/s00280-020-04046-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
6 Geng N, Li Y, Zhang W, Wang F, Wang X, Jin Z, Xing Y, Li D, Zhang H, Li Y, Li X, Cheng M, Jin F, Li F. A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis. Int J Cancer 2020;146:1139-51. [PMID: 31219614 DOI: 10.1002/ijc.32523] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
7 Lee SE, Alcedo KP, Kim HJ, Snider NT. Alternative Splicing in Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;10:699-712. [PMID: 32389640 DOI: 10.1016/j.jcmgh.2020.04.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
8 Lai CY, Yeh DW, Lu CH, Liu YL, Chuang YC, Ruan JW, Kao CY, Huang LR, Chuang TH. Epigenetic Silencing of Ubiquitin Specific Protease 4 by Snail1 Contributes to Macrophage-Dependent Inflammation and Therapeutic Resistance in Lung Cancer. Cancers (Basel) 2020;12:E148. [PMID: 31936290 DOI: 10.3390/cancers12010148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
9 Choi HS, Baek KH. Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes. Cell Mol Life Sci 2022;79:117. [PMID: 35118522 DOI: 10.1007/s00018-022-04132-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Cheng J, Guo J, North BJ, Wang B, Cui C, Li H, Tao K, Zhang L, Wei W. Functional analysis of deubiquitylating enzymes in tumorigenesis and development. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019;1872:188312. [DOI: 10.1016/j.bbcan.2019.188312] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
11 Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J. USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target. Cancer Cell Int 2020;20:298. [PMID: 32669974 DOI: 10.1186/s12935-020-01391-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
12 Zhou C, Bi F, Yuan J, Yang F, Sun S. Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6. J Exp Clin Cancer Res 2018;37:290. [PMID: 30482241 DOI: 10.1186/s13046-018-0951-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
13 Xu J, Chen D, Jin L, Chen Z, Tu Y, Huang X, Xue F, Xu J, Chen M, Wang X, Chen Y. Ubiquitously specific protease 4 inhibitor-Vialinin A attenuates inflammation and fibrosis in S100-induced hepatitis mice through Rheb/mTOR signalling. J Cell Mol Med 2021;25:1140-50. [PMID: 33295107 DOI: 10.1111/jcmm.16180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhou J, Qiu T, Wang T, Chen Z, Ma X, Zhang L, Zou J. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling. Clin Sci (Lond) 2019;133:335-49. [PMID: 30622220 DOI: 10.1042/CS20180959] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
15 Wang Y, Zhou L, Lu J, Jiang B, Liu C, Liang Z, Zhou W, Guo J. Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic cancer. Exp Cell Res 2020;396:112317. [PMID: 33038351 DOI: 10.1016/j.yexcr.2020.112317] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Dong X, Liu Z, Zhang E, Zhang P, Wang Y, Hang J, Li Q. USP39 promotes tumorigenesis by stabilizing and deubiquitinating SP1 protein in hepatocellular carcinoma. Cell Signal 2021;85:110068. [PMID: 34197957 DOI: 10.1016/j.cellsig.2021.110068] [Reference Citation Analysis]
17 Poondla N, Chandrasekaran AP, Kim KS, Ramakrishna S. Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities? BMB Rep 2019;52:181-9. [PMID: 30760385 [PMID: 30760385 DOI: 10.5483/bmbrep.2019.52.3.048] [Cited by in Crossref: 28] [Article Influence: 9.3] [Reference Citation Analysis]
18 Li R, Shang R, Li S, Ren Y, Shen L, Yang L, Chen S, Chen X, Li J, Xu M. LOXL3-promoted hepatocellular carcinoma progression via promotion of Snail1/USP4-mediated epithelial-mesenchymal transition. Environ Toxicol 2022. [PMID: 35841383 DOI: 10.1002/tox.23617] [Reference Citation Analysis]
19 Li S, Zhu Y, Zhang T, Hang Y, Chen Q, Jin Y. Cai's Neiyi Prescription promotes apoptosis and inhibits inflammation in endometrial stromal cells with endometriosis through inhibiting USP10. Biotechnol Appl Biochem 2019;66:231-9. [PMID: 30468519 DOI: 10.1002/bab.1715] [Reference Citation Analysis]
20 Higurashi M, Maruyama T, Nogami Y, Ishikawa F, Yoshida Y, Mori K, Fujita KI, Shibanuma M. High expression of FOXM1 critical for sustaining cell proliferation in mitochondrial DNA-less liver cancer cells. Exp Cell Res 2020;389:111889. [PMID: 32032602 DOI: 10.1016/j.yexcr.2020.111889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]